Delivery Order SPE2DB22D1041-SPE2DB25FUAX2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $3,150.33. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the federal pharmaceutical procurement process. The order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100-count) with a ceiling value of $1,222.60 under a firm fixed price arrangement. The contract was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units. This competitive award carries a ceiling value of $2,436.12 with firm fixed pricing and is scheduled for completion by July 21, 2025. The contract was not designated as a set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $2,469.22. This competitively awarded, firm fixed price delivery order is set to be completed by August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $2,855.75. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. The contract is scheduled...
- The Defense Logistics Agency awarded a delivery order valued at $1,073.04 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count units). This order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed-price, competitively awarded contract with no set-aside designation. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count) with a ceiling value of $1,346.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on April 25, 2025, and performance will occur at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $1,995.16. The contract, awarded on June 9, 2025, with an ultimate completion date of June 10, 2025, was executed under firm fixed price terms with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $2,501.99. This competitive, non-set-aside award was executed on September 11, 2025, with an ultimate completion date of September 12, 2025. The delivery order utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $1,479.44 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUAX2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) on June 18, 2025, with a ceiling value of $1,738.16 and firm fixed pricing. This is a non-set-aside contract with an ultimate completion date of June 20, 2025, and performance will be conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pediatric attention deficit hyperactivity disorder medication supply for federal medical procurement needs. This award is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, continues to demonstrate its capability to fulfill federal procurement requirements through competitive awards, serving the Defense Health Agency and other government healthcare systems with specialty medications, brand-name and generic drugs, and related medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/18/25 |